🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dr. Mark Litwin, chair of UCLA Urology, spoke to the Los Angeles Times about how decades of research, including support from Biden’s own Cancer Moonshot, is now helping treat the very disease the former president is facing.

Dr. Mark Litwin, chair of @UCLAUrology, joined KTLA with Micah Ohlman and cher calvin to break down what an aggressive prostate cancer diagnosis means, including treatment options and key warning signs to watch for. youtube.com/watch?app=desk…

Congratulations to UCLA Health radiation oncologist Matthew J. Farrell on being named the inaugural Hope Fellow of the new Institute for the Study of Hope, Dignity and Wellbeing, a global effort to advance patient-centered care through the science of hope. bit.ly/3SHx54y

AACI and AACR #advocates are on Capitol Hill all day asking members of #Congress for their support of crucial federal funding for cancer research. We'll be posting and sharing highlights. #AACIOnTheHill #AACROnTheHill #FundNIH #FundNCI #DefendingCancerResearch

A new UCLA study shows common antidepressants (SSRIs) boost T cell–mediated antitumor immunity and shrink tumors in preclinical models. Repurposing these FDA-approved drugs could enhance cancer immunotherapy. bit.ly/4knCxW2

A widely used antidepressant drug could help the immune system fight cancer, according to a new research study from UCLA. UCLA Health UCLA Broad Stem Cell UCLA Jonsson Comprehensive Cancer Center newsroom.ucla.edu/stories/antide…

ICYMI: Dr. Leonard Marks of UCLA Health joined CBS News to talk about his latest prostate cancer research and share insights on President Biden’s recent diagnosis. cbsnews.com/losangeles/vid…

In today’s episode of OncLive On Air, Kanwarpal S. Kahlon, MD, of UCLA Jonsson Comprehensive Cancer Center discusses the availability of generic eltrombopag for patients with aplastic anemia and immune thrombocytopenia.  Listen to the full episode here🎧: onclive.com/view/eltrombop… #hematology #oncology

This #BrainCancerAwarenessMonth, CBF highlights the UCLA researchers driving bold breakthroughs—reprogramming tumor cells, developing personalized vaccines and using organoids to tackle glioblastoma. 🧠🔬 Learn more: tinyurl.com/2ps6xc64

A widely used antidepressant drug could help the immune system fight cancer, according to a new research study from UCLA. UCLA Health UCLA Broad Stem Cell UCLA Jonsson Comprehensive Cancer Center newsroom.ucla.edu/stories/antide…

Caring for patients with cholangiocarcinoma is deeply personal. Thank you Cholangiocarcinoma Foundation for sharing my story! UCLA Health cholangiocarcinoma.org/qa-with-dr-tru…

🙏 to Cardiac Interventions Today for 🎙️Ashley Stein-Merlob, MD & me to share our experiences at UCLA Health UCLA Jonsson Comprehensive Cancer Center in #cardioonc program building. It's a Hard, but incredibly rewarding journey. Also see great commentary by Orly Leiva, MD Sara C. Martinez MD PhD Cezar Iliescu! shorturl.at/VpJow

Congratulations to Dr. Andrew Goldstein and team on receiving the Benaroya Prostate Cancer Foundation Challenge Award! The $1M grant supports their groundbreaking work to uncover how prostate cancer spreads to the liver and how to stop it. bit.ly/4kD8A4n

Alicia Buffi, RN, a nurse navigator, meets patients before they leave Ronald Reagan UCLA Medical Center to ensure a seamless transition to outpatient care. Her calming, compassionate approach supports patients throughout their cancer journey. Learn more:

Deborah Wong, MD, PhD, discussed the role of EBV and challenges in nasopharyngeal cancer diagnosis with event participants.UCLA Health hubs.ly/Q03psx2g0

Today at #ASCO25, Dr. Aaron Lisberg presents promising early results on DB-1310, a HER3-targeted antibody-drug conjugate for advanced solid tumors. Don't miss his talk at 2:45pm CST during the Oral Abstract Session of the Developmental Therapeutics Track. bit.ly/4kFwAE3

And we're back to our regularly scheduled programming with Jonathan Goldman, MD, of UCLA Health, who unpacked the LUMINOSITY trial of telisotuzumab vedotin in c-Met–overexpressing, EGFR-wildtype NSCLC. Visit onclive.com to see his insights! #ASCO25 #lcsm #oncology

Thank you everyone who joined us for our ANCO MOASC joint luncheon at #ASCO25! We were so excited to see all the collaborations and relationships forming and had a great time meeting our members in person. City of Hope UC San Francisco Stanford University Cancer at Cedars-Sinai UC San Diego Health Moores Cancer Center

‼️ #ASCO25 simultaneous publication by Maria Antonia Vélez et al:  Adequacy of Immune Checkpoint Inhibitor-Associated Thyroid Function Monitoring Following Therapy. Read the full article: brnw.ch/21wT6os

📍Check out our ASCO poster (Board A136) on the Adequacy of Thyroid Function Monitoring after ICI therapy. ⭐️ Post-ICI thyroid dysfunction is common but often underdiagnosed due to limited surveillance. 🔎 Findings underscore the need for extended TFT monitoring post-treatment.